ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 566

Temporal Relationship Between Enteropathic Spondylitis Symptoms/diagnosis and Inflammatory Bowel Diseases Diagnosis: HUR-BIO Real Life Results

Bayram Farisoğulları1, Gozde Kubra Yardımcı 1, Alper Sarı 1, Berkan Armagan 2, Emre Bilgin 1, Ertugrul Cagri Bolek 1, Levent Kilic 3, Omer Karadag 4, Ali Akdoğan 1, Şule Apras Bilgen 3, Ali İhsan Ertenli 1, Sedat Kiraz 3 and Umut Kalyoncu 5, 1Hacettepe University Vasculitis Centre, Ankara, Turkey, Ankara, Turkey, 2Department of Internal Medicine, Hacettepe University, Faculty of Medicine, Ankara, Turkey., Ankara, Turkey, 3Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey, 4Hacettepe University Vasculitis Centre, Ankara, Turkey / Vasculitis and Lupus Clinic, Addenbrooke’s Hospital, University of Cambridge, UK, Ankara, Turkey, 5Hacettepe University Department of Rheumatology, Ankara, Turkey

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: inflammatory arthritis and spondylarthritis, inflammatory bowel disease (IBD)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster I: Axial Spondyloarthritis, Clinical Features

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: The correlation between the time frame of the symptoms/diagnosis of spondylitis and the diagnosis of inflammatory bowel disease (IBD) on patients of enteropathic spondylitis (eSpA) is not precisely known. Aim of this study was to determine the timing of symptoms/diagnosis of SpA and the diagnosis of IBD on the patients with eSpA.

Methods: HUR-BIO (Hacettepe University Rheumatology Biologic Registry) is a prospective, single center database of biological treatments since 2005. HUR-BIO SpA registry included 2576 SpA patients, and 90 (3.5%) patients had enteropathic arthritis (EA). Sacroiliitis was defined at 59 (65.5%) patients as modified New York criteria or based on ASAS magnetic resonance imaging. Enteropathic spondylitis defined as inflammatory bowel disease and radiological sacroilitis with inflammatory back pain/spine symptoms.  Demographic, clinical, laboratory, therapeutic data and imaging features were collected from this database. Patients with available data about the timing of IBD diagnosis, SpA symptoms and SpA diagnosis were included in the analysis. The temporal relationship between the diagnosis of IBD and the symptom and / or diagnosis of SpA was assessed.

Results: Fifty nine (44.1% female) eSpA patients enrolled in this study. Mean age was 45.0 ± 13.0 years, mean disease duration was 9.9 ± 7.8 years. IBD type was UC in 31 (52.5%) patients, CD in 28 (47.5%) patients. The symptoms of spondylitis were present in 49 (83%) patients before the diagnosis of IBD [CD 96.4% vs UC 71.0%, p=0.009] (Table 1). In 23 patients, SpA diagnosis was made after IBD diagnosis [CD 25% vs UC 51%, p=0.036]. The median time lag between the diagnosis of IBD and SpA was 2 (1-9) years for CD, 7.5 (2-23) years for UC, p=0.027. The mean delay time for the diagnosis of SpA in patients with eSpA was 4 (0-31) years [4 (0-31) years in CD vs 3 (0-22) years UC patients, p:0.57].

Conclusion: In most of eSpA patients, spondylitis symptoms were present before diagnosis of IBD and this finding  was more prominent in CD. On the other hand, the diagnosis of spondylitis was made after the diagnosis of IBD in almost 40% of patients. In UC, this condition was more distinct.


enteropatik artrit süre tablosu-dönüştürüldü


Disclosure: B. Farisoğulları, None; G. Yardımcı, None; A. Sarı, None; B. Armagan, None; E. Bilgin, None; E. Bolek, None; L. Kilic, None; O. Karadag, None; A. Akdoğan, None; �. Apras Bilgen, None; A. Ertenli, None; S. Kiraz, None; U. Kalyoncu, UCB, 5.

To cite this abstract in AMA style:

Farisoğulları B, Yardımcı G, Sarı A, Armagan B, Bilgin E, Bolek E, Kilic L, Karadag O, Akdoğan A, Apras Bilgen �, Ertenli A, Kiraz S, Kalyoncu U. Temporal Relationship Between Enteropathic Spondylitis Symptoms/diagnosis and Inflammatory Bowel Diseases Diagnosis: HUR-BIO Real Life Results [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/temporal-relationship-between-enteropathic-spondylitis-symptoms-diagnosis-and-inflammatory-bowel-diseases-diagnosis-hur-bio-real-life-results/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/temporal-relationship-between-enteropathic-spondylitis-symptoms-diagnosis-and-inflammatory-bowel-diseases-diagnosis-hur-bio-real-life-results/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology